Results 41 to 50 of about 50,069 (258)
Drug poisonings following bariatric surgery: Case series report
British Journal of Clinical Pharmacology, EarlyView.Bariatric surgery alters gastrointestinal anatomy and physiology, which likely impacts upon oral medication absorption. Drug‐ and alcohol‐related deaths in this population are being increasingly reported; however, toxicological detail is lacking. Using data reported to the National Programme on Substance Use Mortality, we identified 18 deaths in people
Eman Mshari +3 more
wiley +1 more source
Harm Reduction JournalBackground Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understand how patients experience medical
Eloise W. Freitag +7 more
doaj +1 more source
BMC Nursing, 2019 Background In Canada, federal regulations allow Nurse Practitioners (NPs) to authorize medical cannabis. Nursing regulatory bodies, however, have been hesitant to include medical cannabis within NPs’ scope of practice.
Lynda G. Balneaves, Abeer A. Alraja
doaj +1 more source
BMJ Open, 2021 Objective To explore values and preferences towards medical cannabis among people living with chronic pain.Design Mixed-methods systematic review.Data sources We searched MEDLINE, EMBASE and PsycINFO from inception to 17 March 2020.Study selection Pairs ...
Linan Zeng +10 more
doaj +1 more source
Salud colectiva, 2022 Health is a human right. In order to guarantee that right, it is fundamental that all activities concerning health in different contexts (clinical, research, teaching) contribute to the construction of an efficient system that promotes excellence, equity, justice, and solidarity.
openaire +2 more sources
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko +9 more
wiley +1 more source
Preventive Medicine ReportsObjectives: We characterized trends in medical cannabis use; examined characteristics associated with medical cannabis use without medical authorization; and examined the association between recreational cannabis legalization and medical cannabis use in ...
Sameer Imtiaz +6 more
doaj +1 more source
A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
BMC Family Practice, 2019 Background Healthcare providers play a critical role in facilitating patient access to medical cannabis. However, previous surveys suggest only a minority of providers believe that medical cannabis confers benefits to patients.
Lindsey M. Philpot +2 more
doaj +1 more source
Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report
Frontiers in Pharmacology, 2022 Cannabidiol (CBD) rich products are successfully used in some countries for treating symptoms associated with autism spectrum disorder (ASD). Yet, CBD provides insufficient intervention in some individuals, or for some characterizing symptoms of ASD ...
Noa Raz +5 more
doaj +1 more source
Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks
British Journal of Clinical Pharmacology, EarlyView.The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou +2 more
wiley +1 more source